default author photo

Veronica S. Russell

Duke University - Duke Human Vaccine Institute

United States

SCHOLARLY PAPERS

1

DOWNLOADS

33

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Oral Hsp90 Inhibitor, SNX-5422, Attenuates SARS-CoV-2 Replication and Dampens Inflammation in Airway Cells

Number of pages: 66 Posted: 12 Mar 2021
Ria Goswami, Veronica S. Russell, Joshua J. Tu, Philip F. Hughes, Francine Kelly, Stephanie N. Langel, Justin Steppe, Scott M. Palmer, Timothy Haystead, Maria Blasi and Sallie Permar
Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Department of Pharmacology and Cancer Biology, Duke University - Division of Pulmonary, Allergy and Critical Care Medicine, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Division of Pulmonary, Allergy and Critical Care Medicine, Duke University - Department of Pharmacology and Cancer Biology, Duke University - Duke Human Vaccine Institute and Duke University - Department of Molecular Genetics and Microbiology
Downloads 33 (1,277,121)

Abstract:

Loading...

COVID-19, SARS-CoV-2, Hsp90, Post-exposure prophylaxis, anti-inflammatory, host directed therapy, orally bioavailable